How does thyroid function affect fertility and pregnancy?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
Untreated hypothyroidism reduces fertility and raises the risk of miscarriage, pre-eclampsia, low birthweight and impaired fetal brain development. Women already taking levothyroxine usually need more of it during pregnancy. The 2026 American Thyroid Association guideline made the approach more conservative: confirm mild abnormalities before treating, and do not give levothyroxine to euthyroid antibody-positive women with infertility.
Thyroid function matters in pregnancy for two reasons. The fetal thyroid does not start working until roughly the middle of the first half of pregnancy, so early fetal brain development depends on maternal thyroid hormone. And thyroid hormone requirement rises during pregnancy, so a dose that was correct before conception often is not. The 2026 American Thyroid Association guideline for preconception, pregnancy and postpartum is the current reference and it changed several long-standing habits.
Before pregnancy
For a woman already taking levothyroxine and planning pregnancy, the 2026 guideline describes a TSH between 0.5 and 2.5 mU/L as a reasonable treatment target, and suggests rechecking TSH and free T4 every 3 to 6 months while pregnancy is being planned. It also moved away from universal screening: clinicians are advised to evaluate every newly pregnant patient for thyroid disease risk factors and offer TSH testing to those at increased risk.
The change on thyroid antibodies
This is the most significant reversal. Euthyroid women with positive TPO or thyroglobulin antibodies were often given levothyroxine to reduce miscarriage risk. High-quality randomised trials did not show benefit. The 2026 guideline gives a strong recommendation, supported by high-quality evidence, that "for euthyroid TPOAb and/or TgAb positive women with infertility, levothyroxine treatment should not be offered." The same applies to fertility treatment and recurrent pregnancy loss. Monitoring replaces medication.
During pregnancy
Where local trimester-specific reference intervals are unavailable, the 2026 guideline states that a TSH interval of 0.1 to 4.0 mU/L can be used in the first and second trimesters. Levothyroxine is recommended when TSH exceeds 10 mU/L regardless of trimester. For milder elevations the guideline advises confirmatory retesting within 4 to 6 weeks before starting treatment, noting that at least half of mild abnormalities normalise within several weeks. Thyroid function testing is performed at pregnancy confirmation and about every 4 weeks through the first half of pregnancy. T3-containing therapy should be avoided.
| Situation | 2026 ATA approach |
|---|---|
| Already on levothyroxine, planning pregnancy | Target TSH 0.5 to 2.5 mU/L; recheck every 3 to 6 months |
| Newly pregnant | Risk-based TSH testing, not universal screening |
| TSH above 10 mU/L in pregnancy | Treat with levothyroxine, any trimester |
| Mildly raised TSH, especially under 6 mU/L | Repeat in 4 to 6 weeks before treating |
| Euthyroid, TPO antibody positive, infertility | Levothyroxine should not be offered |
| Taking liothyronine or desiccated thyroid | Switch off T3-containing therapy |
If you take levothyroxine and are trying to conceive, arrange thyroid testing as soon as a pregnancy test is positive rather than waiting for the first prenatal visit. Iodine intake of 250 mcg daily is recommended in pregnancy and lactation, usually as a prenatal vitamin containing 150 mcg.
The clinical detail
Hypothyroidism complicates 2 to 3 of every 100 pregnancies and hyperthyroidism 1 to 4 of every 1,000. The National Institute of Diabetes and Digestive and Kidney Diseases advises women already on levothyroxine to take two extra doses per week starting as soon as pregnancy is confirmed, with testing every 4 to 6 weeks in the first half of pregnancy and at least once after 30 weeks.
For Graves' disease, propylthiouracil is used in the first trimester because of methimazole embryopathy risk, with a switch considered thereafter. TSH receptor antibody crosses the placenta and is monitored, since it can cause fetal or neonatal thyrotoxicosis. Postpartum thyroiditis affects roughly 1 in 20 women in the first year after delivery and passes through thyrotoxic and hypothyroid phases. Centres whose non-pregnant TSH upper limit exceeds 4.5 mU/L may reasonably subtract 0.5 mU/L for pregnancy.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. American Thyroid Association. PMID 42219800
- Pregnancy and Thyroid Disease. National Institute of Diabetes and Digestive and Kidney Diseases
- New ATA Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. American Thyroid Association
- Levothyroxine Sodium Tablets Prescribing Information. U.S. Food and Drug Administration
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.